FMS Ena Home, Llc is a medicare approved dialysis facility center in Tarboro, North Carolina and it has 0 dialysis stations. It is located in Edgecombe county at 122 Hospital Drive, Tarboro, NC, 27886.
You can reach out to the office of FMS Ena Home, Llc at (252) 824-0017. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMS Ena Home, Llc has the following ownership type - Profit. It was first certified by medicare in October, 2017. The medicare id for this facility is 342721 and it accepts patients under medicare ESRD program.
Dialysis Center Profile
| Name | FMS Ena Home, Llc |
|---|
| Location | 122 Hospital Drive, Tarboro, North Carolina |
|---|
| No. of Dialysis Stations | 0 |
|---|
| Medicare ID | 342721 |
|---|
| Managed By | Fresenius Medical Care |
|---|
| Ownership Type | Profit |
|---|
| Late Shifts | No |
|---|
NPI Associated with this Dialysis Facility:
Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with FMS Ena Home, Llc
from NPPES records by matching pattern on the basis of name, address, phone number etc.
Please use this information accordingly.
| NPI Number | 1487197406 |
| Organization Name | Edgecombe Home Dialysis |
| Doing Business As | Fms Ena Home, Llc |
| Address | 122 Hospital Drive Tarboro, North Carolina, 27886 |
| Phone Number | (252) 824-0017 |
Patient Distribution
Dialysis Adequacy
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Mineral and Bone Disorder
An important goal of dialysis is to maintain normal levels of various minerals
in the body, such as calcium. This shows the percentage of patients
treated at FMS Ena Home, Llc with elevated calcium levels.
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 1 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL | |